- Home
- NSTS vs VANI Comparison
NSTS vs VANI Comparison
Compare NSTS & VANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NSTS
- VANI
- Stock Information
- Founded
- NSTS 1921
- VANI 1998
- Country
- NSTS United States
- VANI United States
- Employees
- NSTS N/A
- VANI N/A
- Industry
- NSTS Savings Institutions
- VANI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- NSTS Finance
- VANI Health Care
- Exchange
- NSTS Nasdaq
- VANI Nasdaq
- Market Cap
- NSTS 65.8M
- VANI 69.3M
- IPO Year
- NSTS N/A
- VANI 2014
- Fundamental
- Price
- NSTS $12.50
- VANI $1.15
- Analyst Decision
- NSTS
- VANI Strong Buy
- Analyst Count
- NSTS 0
- VANI 1
- Target Price
- NSTS N/A
- VANI $3.00
- AVG Volume (30 Days)
- NSTS 4.9K
- VANI 83.2K
- Earning Date
- NSTS 03-27-2025
- VANI 03-25-2025
- Dividend Yield
- NSTS N/A
- VANI N/A
- EPS Growth
- NSTS N/A
- VANI N/A
- EPS
- NSTS N/A
- VANI N/A
- Revenue
- NSTS $6,117,000.00
- VANI N/A
- Revenue This Year
- NSTS N/A
- VANI N/A
- Revenue Next Year
- NSTS N/A
- VANI N/A
- P/E Ratio
- NSTS N/A
- VANI N/A
- Revenue Growth
- NSTS N/A
- VANI N/A
- 52 Week Low
- NSTS $9.35
- VANI $1.01
- 52 Week High
- NSTS $13.32
- VANI $7.80
- Technical
- Relative Strength Index (RSI)
- NSTS 54.29
- VANI 43.02
- Support Level
- NSTS $12.31
- VANI $1.12
- Resistance Level
- NSTS $12.90
- VANI $1.19
- Average True Range (ATR)
- NSTS 0.24
- VANI 0.03
- MACD
- NSTS -0.07
- VANI 0.00
- Stochastic Oscillator
- NSTS 34.40
- VANI 42.86
About NSTS NSTS Bancorp Inc.
NSTS Bancorp Inc is a savings and loan holding company regulated Federal Reserve Board. The company was formed to serve as the North Shore Trust and Savings stock holding company. The Bank is a wholly-owned subsidiary of the company and operates as a traditional savings institution focused on serving the banking needs of customers in our market area of Lake County, Illinois and adjacent communities.
About VANI Vivani Medical Inc. (DE)
Vivani Medical Inc is a preclinical-stage biopharmaceutical company. It develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division.